Brief: Frequency Therapeutics - Expects Existing Cash, Cash Equivalents, Marketable Securities To Be Sufficient To Fund Operations Into 2023

Korro Bio

12/08/2021 12:36

Aug 12 (Reuters) - Frequency Therapeutics Inc  FREQ.O :
    * FREQUENCY THERAPEUTICS - EXPECTS EXISTING CASH, CASH
EQUIVALENTS, MARKETABLE SECURITIES TO BE SUFFICIENT TO FUND
OPERATIONS INTO 2023
    * QTRLY REVENUE $9.4 MILLION VERSUS $8.5 MILLION
    * QTRLY LOSS PER SHARE $0.52
    * Q2 EARNINGS PER SHARE VIEW $-0.51, REVENUE VIEW $6.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw2CTvw1a 
Further company coverage:  FREQ.O 

 ((Reuters.Briefs@thomsonreuters.com;))